|
시장보고서
상품코드
2125956
액체 생검 시장(2026-2030년)Global Liquid Biopsy Market 2026-2030 |
||||||
세계의 액체 생검 시장은 2025년부터 2030년까지 51억 1,520만 달러 증가하고, 예측 기간 동안 CAGR은 24.3%에 달할 것으로 예측됩니다.
세계 액체 생검 시장에 관한 본 보고서는 종합적인 분석, 시장 규모 및 전망, 동향, 성장 요인, 과제는 물론 약 25개 업체를 대상으로 한 벤더 분석을 제공합니다.
본 보고서는 현재의 시장 상황, 최신 동향 및 촉진요인, 그리고 전반적인 시장 환경에 대한 최신 분석을 제공합니다. 이 시장의 성장을 주도하는 요인으로는 전 세계 암 질환 부담의 증가, 맞춤형 의료로의 전환, 유전체 시퀀싱 분야의 기술 혁신 및 분석 감도 향상, 질환의 경과 모니터링 및 미세 잔류 병변 평가의 필요성 등이 있습니다.
본 조사는 업계 주요 관계자로부터 얻은 정보를 포함한 1차 정보와 2차 정보를 객관적으로 결합하여 수행되었습니다. 본 보고서에는 주요 기업에 대한 분석 외에도 종합적인 시장 규모 데이터, 지역별 분석이 포함된 부문, 그리고 벤더 현황이 담겨 있습니다. 보고서에는 과거 데이터 및 예측 데이터가 포함되어 있습니다.
| 시장 범위 | |
|---|---|
| 기준 연도 | 2025년 |
| 종료 연도 | 2030년 |
| 조사 기간 | 2026-2030년 |
| 성장 모멘텀 | 가속 |
| 2026년 전년 대비 | 22.7% |
| CAGR | 24.3% |
| 증가액 | 51억 1,520만 달러 |
본 조사에서는 향후 수년간 전 세계 액체 생검 시장의 성장을 견인할 주요 요인 중 하나로, 다종 암 조기 검출 조사 기법의 등장과 보급을 꼽고 있습니다. 또한, 정확도 향상을 위한 멀티오믹스 통합 및 후성유전학적 프로파일링으로의 전환, 그리고 데이터 해석에 있어 AI와 첨단 바이오인포매틱스의 광범위한 통합이 시장에서 상당한 수요를 창출할 것으로 예상됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
제3장 시장 구도
제4장 시장 규모
제5장 시장 규모 실적
제6장 정성 분석
제7장 Five Forces 분석
제8장 시장 세분화 : 용도별
제9장 시장 세분화 : 기술별
제10장 시장 세분화 : 최종사용자별
제11장 고객 상황
제12장 지역별 상황
제13장 촉진요인, 과제, 기회
제14장 경쟁 구도
제15장 경쟁 분석
제16장 부록
KSM 26.09.08The global liquid biopsy market is forecasted to grow by USD 5115.2 mn during 2025-2030, accelerating at a CAGR of 24.3% during the forecast period. The report on the global liquid biopsy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global burden of oncological conditions and shift toward personalized medicine, technological innovations in genomic sequencing and enhanced analytical sensitivity, necessity for longitudinal disease monitoring and minimal residual disease assessment.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 22.7% |
| CAGR | 24.3% |
| Incremental Value | $5115.2 mn |
Technavio's global liquid biopsy market is segmented as below:
By Application
- Cancer applications
- Non-cancer applications
By Technology
- CTC and ctDNA
- Exosome and RNA
By End-User
- Hospitals
- Clinical laboratories
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the emergence and proliferation of multi-cancer early detection methodologies as one of the prime reasons driving the global liquid biopsy market growth during the next few years. Also, shift toward multi-omic integration and epigenetic profiling for enhanced accuracy and pervasive integration of ai and advanced bioinformatics in data interpretation will lead to sizable demand in the market.
The report on the global liquid biopsy market covers the following areas:
- Global liquid biopsy market sizing
- Global liquid biopsy market forecast
- Global liquid biopsy market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global liquid biopsy market vendors that include A. Menarini Industrie Farma, Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio Techne Corp., Burning Rock Biotech Ltd., Cellbox Solutions GmbH, Exact Sciences Corp., F. Hoffmann La Roche Ltd., GRAIL Inc., Illumina Inc., Laboratory Holdings Inc., Lucence Health Inc., MDXHEALTH SA, Myriad Genetics Inc., Natera Inc., NeoGenomics Laboratories Inc., QIAGEN N.V., Sysmex Corp., Thermo Fisher Scientific Inc., Veracyte Inc.. Also, the global liquid biopsy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Liquid Biopsy Market 2020 - 2024
- Historic Market Size - Data Table on Global Liquid Biopsy Market 2020 - 2024 ($ million)
- 5.2 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.3 Technology segment analysis 2020 - 2024
- Historic Market Size - Technology Segment 2020 - 2024 ($ million)
- 5.4 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Liquid Biopsy Market
- 6.2 Impact of Geopolitical Conflicts on Global Liquid Biopsy Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Application
- 8.1 Market segments
- 8.2 Comparison by Application
- 8.3 Cancer applications - Market size and forecast 2025-2030
- 8.4 Non-cancer applications - Market size and forecast 2025-2030
- 8.5 Market opportunity by Application
- Market opportunity by Application ($ million)
9 Market Segmentation by Technology
- 9.1 Market segments
- 9.2 Comparison by Technology
- 9.3 CTC and ctDNA - Market size and forecast 2025-2030
- 9.4 Exosome and RNA - Market size and forecast 2025-2030
- 9.5 Market opportunity by Technology
- Market opportunity by Technology ($ million)
10 Market Segmentation by End-user
- 10.1 Market segments
- 10.2 Comparison by End-user
- 10.3 Hospitals - Market size and forecast 2025-2030
- 10.4 Clinical laboratories - Market size and forecast 2025-2030
- 10.5 Others - Market size and forecast 2025-2030
- 10.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Singapore - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 South Africa - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Chile - Market size and forecast 2025-2030
- 12.6.7 Israel - Market size and forecast 2025-2030
- 12.6.8 Egypt - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rising global burden of oncological conditions and shift toward personalized medicine
- Technological innovations in genomic sequencing and enhanced analytical sensitivity
- Necessity for longitudinal disease monitoring and minimal residual disease assessment
- 13.2 Market challenges
- High financial requirements and absence of standardized reimbursement frameworks
- Technical limitations and necessity for biological precision
- Stringent regulatory environments and requirement for proven clinical utility
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Emergence and proliferation of multi-cancer early detection methodologies
- Shift toward multi-omic integration and epigenetic profiling for enhanced accuracy
- Pervasive integration of AI and advanced bioinformatics in data interpretation
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 A. Menarini Industrie Farma
- A. Menarini Industrie Farma - Overview
- A. Menarini Industrie Farma - Product / Service
- A. Menarini Industrie Farma - Key offerings
- SWOT
- 15.5 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
- 15.6 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 15.7 Bio Techne Corp.
- Bio Techne Corp. - Overview
- Bio Techne Corp. - Business segments
- Bio Techne Corp. - Key news
- Bio Techne Corp. - Key offerings
- Bio Techne Corp. - Segment focus
- SWOT
- 15.8 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.9 Laboratory Holdings Inc.
- Laboratory Holdings Inc. - Overview
- Laboratory Holdings Inc. - Business segments
- Laboratory Holdings Inc. - Key offerings
- Laboratory Holdings Inc. - Segment focus
- SWOT
- 15.10 Lucence Health Inc.
- Lucence Health Inc. - Overview
- Lucence Health Inc. - Product / Service
- Lucence Health Inc. - Key offerings
- SWOT
- 15.11 MDXHEALTH SA
- MDXHEALTH SA - Overview
- MDXHEALTH SA - Product / Service
- MDXHEALTH SA - Key offerings
- SWOT
- 15.12 Myriad Genetics Inc.
- Myriad Genetics Inc. - Overview
- Myriad Genetics Inc. - Product / Service
- Myriad Genetics Inc. - Key offerings
- SWOT
- 15.13 Natera Inc.
- Natera Inc. - Overview
- Natera Inc. - Business segments
- Natera Inc. - Key offerings
- Natera Inc. - Segment focus
- SWOT
- 15.14 NeoGenomics Laboratories Inc.
- NeoGenomics Laboratories Inc. - Overview
- NeoGenomics Laboratories Inc. - Business segments
- NeoGenomics Laboratories Inc. - Key offerings
- NeoGenomics Laboratories Inc. - Segment focus
- SWOT
- 15.15 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key offerings
- SWOT
- 15.16 Sysmex Corp.
- Sysmex Corp. - Overview
- Sysmex Corp. - Business segments
- Sysmex Corp. - Key offerings
- Sysmex Corp. - Segment focus
- SWOT
- 15.17 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
- 15.18 Veracyte Inc.
- Veracyte Inc. - Overview
- Veracyte Inc. - Product / Service
- Veracyte Inc. - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
